Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,291 | -22,436 | -15,737 | -8,790 | -33,904 |
| Depreciation Amortization | 2,553 | 1,867 | 1,212 | 599 | 2,931 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -70 |
| Accounts receivable | 4,801 | 6,189 | 7,186 | 1,561 | -8,010 |
| Other Working Capital | 2,038 | 5,160 | 5,044 | 38 | -12,157 |
| Other Operating Activity | 1,205 | -643 | -2,507 | 2,223 | 20,324 |
| Operating Cash Flow | $-12,694 | $-9,862 | $-4,802 | $-4,369 | $-30,886 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,451 | -1,481 | -1,135 | -287 | -1,824 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -33 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -33 |
| Investing Cash Flow | $-1,451 | $-1,481 | $-1,135 | $-287 | $-1,858 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -971 | -352 | -34 | -17 | -62 |
| Common Stock Issued | 4,312 | 3,923 | N/A | N/A | 38,898 |
| Other Financing Activity | 26 | -40 | -40 | -39 | -145 |
| Financing Cash Flow | $3,367 | $3,531 | $-74 | $-55 | $38,690 |
| Exchange Rate Effect | 184 | 94 | 76 | 337 | -240 |
| Beginning Cash Position | 28,773 | 28,773 | 28,773 | 28,773 | 23,066 |
| End Cash Position | 18,179 | 21,055 | 22,838 | 24,399 | 28,773 |
| Net Cash Flow | $-10,594 | $-7,718 | $-5,935 | $-4,374 | $5,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,694 | -9,862 | -4,802 | -4,369 | -30,886 |
| Capital Expenditure | -1,451 | -1,481 | -1,135 | -287 | -1,824 |
| Free Cash Flow | -14,145 | -11,343 | -5,937 | -4,656 | -32,710 |